The study results show that – 80% of percutaneous tibial nerve stimulation (PTNS) patients considered themselves cured or improved, while 55% of tolterodine LA patients considered themselves cured or improved. Physicians considered 80% of PTNS patients cured or improved, compared with 61% of tolterodine LA patients. The frequency of voiding episodes was reduced in 73% of PTNS patients versus 74% of tolterodine LA patients.
The Urgent PC System is a proprietary, minimally invasive percutaneous tibial nerve stimulation device designed for office-based treatment of urinary urgency, urinary frequency and urge incontinence, symptoms often associated with overactive bladder.
Dave Kaysen, president and CEO of Uroplasty, said: “These results demonstrate that the Urgent PC is an effective and viable non-drug option for treating the urinary symptoms often associated with overactive bladder.”